Epigenetics Market Revenue to Cross USD 4.1 billion by 2030 | CAGR of 14.8%
According to the report published by Allied Market Research, the global epigenetics market was estimated at $1.0 billion in 2020 and is expected to hit $4.1 billion by 2030, registering a CAGR of 14.8% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.
Key Takeaways:
- High-end technological advancements associated with epigenetics, rise in incidences of cancer, surge in genome mapping programs, and growing number of R&D activities drive the global epigenetics market.
- Standardization concerns over epigenetics-based diagnostics and dearth of skilled professionals impede the growth to some extent.
- Several growth opportunities in the emerging economies have created an array of lucrative prospects for the key players in the industry.
- North America dominates the global epigenetics market.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/846
Covid-19 Scenario-
- Rise in number of epigenetic researches and increase in awareness of epigenetic drugs for the treatment of coronavirus infection has had a positive impact on the global epigenetics market.
- This drift is most likely to continue till the pandemic is completely over.
Research Methodology
The research operandi of the global class epigenetic market includes significant primary as well as secondary research. When the primary methodology encompasses widespread discussion with a plethora of valued participants, the secondary research involves a substantial amount of product/service descriptions. Furthermore, several government sites, industry bulletins, and press releases have also been properly examined to bring forth high-value industry insights.
Key Market Segments
- By Product
- Reagents
- Enzymes
- Instruments
- Kits
By Application
- Oncology
- Non Oncology
By End User
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contrac Research Organizations
By Region North
- America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
- LAMEA (Middle East And Africa, Latin America)
Request for Customization https://www.alliedmarketresearch.com/request-for-customization/846
The growth of the global epigenetics market is attributed to increase in oncology cases, surge of other chronic diseases and its rising application for non-oncology applications. Moreover, increase in R & D for epigenetics is expected to further drive the market growth during the forecast period.
Regional Growth Dynamics
The epigenetics market size of North America generated revenue worth $468.84 million in 2020, and is anticipated to dominate the global epigenetics market in the future. This is attributed to developed healthcare infrastructure, wide availability of advanced epigenetics products, large presence of key players, and presence of trained medical professionals. However, Asia-Pacific is expected to witness highest growth rate during the forecast period, owing to rise in awareness related to epigenetics industry, increase in penetration of key players in emerging countries in Asia-Pacific, and development in infrastructure for research and clinical settings.
Ask to Our Industry Expert:
https://www.alliedmarketresearch.com/purchase-enquiry/846
Key players in the industry-
- Abcam Plc.
- PerkinElmer, Inc.
- Zymo Research
- QIAGEN N.V.
- Merck Millipore
- Agilent Technologies, Inc.
- Illumina Inc.
- Active Motif, Inc.
- Hologic Inc.
- Thermo Fisher Scientific Inc.
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
Editor Details
-
Company:
- The Wire Times
